FIELD: medicine.
SUBSTANCE: method involves administering macrolide preparation of azithromycin. The drug is applied in concentrations 10 and 30 mg/kg once a day during 7 days. Then, skin flap necrosis zone dimensions are measured and lipid peroxidation intensity is determined.
EFFECT: wide range of functional applications.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RESTRICTING NECROSIS AREA AT MODELING CORONAROOCCLUSION MYOCARDIAL INFARCTION IN ANIMALS AT DECREASED ANTIOXIDANT BACKGROUND | 2002 |
|
RU2226101C2 |
METHOD FOR RESTRICTING THE NECROSIS AREA WITH CLARITROMYCIN WHILE MODELING CORONARY OCCLUSION MYOCARDIAL INFARCTION IN ANIMALS | 2006 |
|
RU2318507C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIC TISSUES SURVIVAL RATE IN REDUCED BLOOD CIRCULATION ENVIRONMENT | 2010 |
|
RU2438190C1 |
METHOD FOR IMPROVING SURVIVAL RATE OF ISCHEMIC TISSUES (ISOLATED SKIN PEDICLE FLAP) IN REDUCED BLOOD CIRCULATION | 2010 |
|
RU2429547C1 |
METHOD FOR RESTRICTING THE NECROSIS AREA WITH ROXYTROMYCIN WHILE MODELING CORONARY OCCLUSION MYOCARDIAL INFARCTION IN ANIMALS | 2006 |
|
RU2318506C1 |
SKIN GRAFTING TECHNIQUE | 2010 |
|
RU2446833C2 |
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH RESVERATROL | 2012 |
|
RU2511061C1 |
METHOD FOR PHARMACOLOGICAL STIMULATION OF PEDICLE SKIN FLAP SURVIVAL WITH NICORANDYL | 2012 |
|
RU2507598C1 |
METHOD FOR INCREASING SKIN GRAFT SURVIVAL IN REDUCED CIRCULATION ENVIRONMENT WITH USE OF DIHYDROQUERCETIN | 2014 |
|
RU2547786C1 |
METHOD FOR AZITHROMYCIN-BASED ENDOTHELIAL DYSFUNCTION CORRECTION IN EXPERIMENTAL REACTIVE VASCULITIS | 2009 |
|
RU2402333C1 |
Authors
Dates
2006-09-10—Published
2002-05-27—Filed